Publicaciones en colaboración con investigadores/as de University of Paris-Saclay (3)

2019

  1. Erratum to: Lipid management in patients with chronic kidney disease (Nature Reviews Nephrology, (2018), 14, 12, (727-749), 10.1038/s41581-018-0072-9)

    Nature Reviews Nephrology

  2. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 208-230

2018

  1. Lipid management in patients with chronic kidney disease

    Nature Reviews Nephrology, Vol. 14, Núm. 12, pp. 727-749